Helsinn Therapeutics (US) Inc.

1160 US Highway 22
Suite 104
New Jersey
United States

Tel: 908-203-6549
Fax: 908-231-1459

Show jobs for this employer

About Helsinn Therapeutics (US) Inc.

Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and subsidiaries in Ireland and the USA. The Helsinn Group has been built on the basis of a licensing of pharmaceuticals, with the recent addition of medical devices in therapeutic niche areas. Helsinn is an important player in Cancer Supportive Care and sells its products through unique business model that is focused on the in- and out- distributors in 87 countries worldwide. Helsinn Therapeutics (U.S.), Inc. was established in January, 2009 and is currently developing clinical and preclinical stage ghrelin receptor agonists and antagonists in cancer and gastrointestinal supportive care. The company’s vision is to become a leading specialty company focused on supportive care with direct sales in the U.S. market.

12 articles with Helsinn Therapeutics (US) Inc.